Form 4 for OPRX OptimizeRx Corp
Accepted 2022-01-11 00:00:00 ET · period of report 2022-01-07 · accession 0001213900-22-001562 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-11 | 2022-01-07 | OPRX | FEBBO WILLIAM J | CEO, Dir | F - Tax | — | +9,627 | 479.0K | +2% | — |
| D | 2022-01-11 | 2022-01-07 | OPRX | FEBBO WILLIAM J | CEO, Dir | F - Tax | $0.00 | -9,627 | 19.3K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-07 | F | A | 9,627 | — | 479,004 | D | — | — | (F1) The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 1/3 at the end of each anniversary from issuance. |
| 2 | Derivative | Unvested Restricted Stock Award | 2022-01-07 | F | D | 9,627 | $0.00 | 19,256 | D | — · — to 2024-01-07 | 28,883 Common Stock | (F1) The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 1/3 at the end of each anniversary from issuance. |